Outcomes of total hip arthroplasty in pancytopenia

Abstract

Objective: Pancytopenia is a hematological entity, it confronts surgeons from time to time, and the purpose was to determine the risks, difficulties and complications involved in performing total hip arthroplasty in pancytopenic patients. Materials and methods: single centre review of 15 patients with pancytopenia, who underwent THA. 5 patients had decreased bone marrow function, 9 increased peripherial destruction, 8 of them had chronic hepatitis with liver cirrhosis (hepatitic C in 6 and B in 2 cases). Results: 18 THA procedures, three patients had staged bilateral THA. Average age was 63.9 years. 12 women and 3 men, 14 cementless and 4 hybrid THA-s. Average intraoperative blood loss was 930 ml, average operative time 72 min. Conclusion: THA in pancytopenia may be challenging and burdened by higher risks and costs, than in cases of some other comorbidities. THA can be safely performed, if thorough preoperative assessment is conducted, proven and safe surgical technique used and adequate postoperative restoration of hematological imbalances achieved. [Arch Clin Exp Surg 2016; 5(4.000): 222-227]

Keywords

• Hip arthroplasty
• pancytopenia
• cryoprecipitate
• cementless
• hybrid